Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

MANKIND PHARMA LTD.

NSE : MANKINDBSE : 543904ISIN CODE : INE634S01028Industry : Pharmaceuticals & DrugsHouse : Private

BSE2092.10-98.55 (-4.5 %)

PREV CLOSE ( ) 2190.65

OPEN PRICE ( ) 2279.90

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 107017

TODAY'S LOW / HIGH ( )2063.75 2294.90

52 WK LOW / HIGH ( )1240.75 2488.65

NSE2092.55-98.2 (-4.48 %)

PREV CLOSE( ) 2190.75

OPEN PRICE ( ) 2281.00

BID PRICE (QTY) 2092.55 (709)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3462277

TODAY'S LOW / HIGH( ) 2060.00 2299.00

52 WK LOW / HIGH ( )1242 2490

Quarters

Select year

( in Million)

Particulars

Mar 2024

Dec 2023

Sep 2023

Jun 2023

Audited / UnAudited

UnAudited

Net Sales

24410.99

26069.59

27080.99

25786.18

Total Expenditure

18499.96

20004.54

20254.54

19238.02

PBIDT (Excl OI)

5911.03

6065.05

6826.45

6548.16

Other Income

921.28

701.33

599.78

586.19

Operating Profit

6832.31

6766.38

7426.23

7134.34

Interest

93.82

91.85

86.24

63.4

Exceptional Items

PBDT

6738.49

6674.53

7339.99

7070.94

Depreciation

1046.88

1097.27

964.85

873.55

Profit Before Tax

5691.61

5577.26

6375.14

6197.39

Tax

949.84

1025.16

1298.1

1302.77

Provisions and contingencies

Profit After Tax

4741.77

4552.1

5077.04

4894.62

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

4741.77

4552.1

5077.04

4894.62

Minority Interest

-53.54

-60.54

-101.51

-73.16

Shares of Associates

24.14

46.02

34.71

47.26

Other related items

Misc. Expenses Written off

Consolidated Net Profit

4712.38

4537.6

5010.26

4868.72

Equity Capital

400.59

Face Value (IN RS)

Reserves

Calculated EPS

11.76

11.32

12.50

12.15

Calculated EPS (Annualised)

47.05

45.30

50.02

48.61

No of Public Share Holdings

100627828

94138294

% of Public Share Holdings

25.12

23.49

23.5

PBIDTM% (Excl OI)

24.21

23.26

25.20

25.39

PBIDTM%

27.98

25.95

27.42

27.66

PBDTM%

27.60

25.60

27.10

27.42

PBTM%

23.31

21.39

23.54

24.03

PATM%

19.42

17.46

18.74

18.98

Notes

Risk Disclosures on Derivatives

Quarterly Results

MANKIND PHARMA LTD.